This open-label extension booster study followed a Phase III study of @ adults who had received two @ g doses of primary AS@A-adjuvanted or non-adjuvanted H@N@ split-virus vaccine ( A/Vietnam/@ / @ ; clade @ ) ( NCT@ ) .